Antheia
PrivateLast Round
Series C
1/27/2026
Total Funding Raised
$380M
Momentum Score
25 /100
Company Overview
Antheia is a biotechnology company that develops cost-effective, plant-based medicines using synthetic biology, informatics, and fermentation technology to create active pharmaceutical ingredients from beneficial plant molecules for healthier patient care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antheia Comps
Public and private peers based on sector, stage, and business model.
Antheia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | 1/27/2026 | ||||
| Series C | 6/3/2025 | ||||
| Grant | 12/3/2024 | ||||
| Strategic | 7/19/2024 | ||||
| Series C | 1/24/2024 | ||||
Debt | 6/22/2022 |
Key People
Founding team and executive leadership
Antheia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sherpalo Ventures | Series C, Series B |
| America's Frontier Fund | Series C |
| Athos KG | Series C |
| EDBI | Series C |
| S-Cubed Capital | Series C |
| Hillspire | Series B |
| Viking Global Investors | Series C, Strategic, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2026
$80M Series C round completed.
- Oct 21, 2025
Eric d'Esparbes appointed as Chief Financial Officer.
Antheia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antheia's valuation, stock price, and market status.